Breaking

Top 5 Canadian Mining Stocks This Week: Avanti Gold Gains 158 Percent on Misisi Settlement
JZR Gold Inc. Announces Private Placement Offering of Units to Raise Up To $1,500,000
Inside longtime Biden aide’s marathon closed-door grilling in House GOP cover-up probe
David Gergen, trusted White House advisor to 4 US presidents across decades, dies at 83
Who is Ashley Williams, the longtime Biden aide grilled by House GOP investigators Friday?
Jasmine Crockett rips Trump ‘regime,’ vows ‘solidarity’ with Biden witnesses during House probe
DoD Invests US$400 Million in Rare Earth Firm MP Materials
Crypto Market Recap: Bitcoin Hits All-Time High as ETF Inflows and Legislation Align

Politics
Business
World
Investing
Search for:

Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

December 20, 2024

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

Top 5 Canadian Mining Stocks This Week: Avanti Gold Gains 158 Percent on Misisi Settlement

JZR Gold Inc. Announces Private Placement Offering of Units to Raise Up To $1,500,000

DoD Invests US$400 Million in Rare Earth Firm MP Materials

Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Categories
- Business (1,743)
- Investing (5,418)
- Politics (8,428)
- Uncategorized (3)
- World (6,680)

Disclaimer: startyourinvesting.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest

Copyright © 2025 startyourinvesting.com | All Rights Reserved

Top

Politics
Business
World
Investing

Type above and press Enter to search. Press Esc to cancel.